Design of Adaptive Phase 1 Clinical Trials for Dose Escalation using the DEDUCE Application

Поділитися
Вставка
  • Опубліковано 28 лис 2024

КОМЕНТАРІ • 2

  • @aeky168
    @aeky168 2 роки тому +1

    What is advantage of 3+3 design?

    • @thepartnership800
      @thepartnership800  2 роки тому

      Response from Dr. London: "easy to understand and conduct;
      well known in the oncology scientific community;
      requires very little time from a statistician, and therefore could be a lower cost"